vs
Side-by-side financial comparison of Carlyle Group Inc. (CG) and Quest Diagnostics (DGX). Click either name above to swap in a different company.
Quest Diagnostics is the larger business by last-quarter revenue ($2.9B vs $1.9B, roughly 1.5× Carlyle Group Inc.). Carlyle Group Inc. runs the higher net margin — 18.8% vs 9.7%, a 9.1% gap on every dollar of revenue. On growth, Carlyle Group Inc. posted the faster year-over-year revenue change (84.1% vs 9.2%). Over the past eight quarters, Carlyle Group Inc.'s revenue compounded faster (66.2% CAGR vs 9.9%).
The Carlyle Group Inc. is an American multinational company with operations in private equity, alternative asset management and financial services. As of 2023, the company had $426 billion of assets under management.
Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.
CG vs DGX — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.9B | $2.9B |
| Net Profit | $358.1M | $281.0M |
| Gross Margin | — | — |
| Operating Margin | 24.3% | 15.4% |
| Net Margin | 18.8% | 9.7% |
| Revenue YoY | 84.1% | 9.2% |
| Net Profit YoY | 69.8% | 12.0% |
| EPS (diluted) | $0.96 | $2.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $2.9B | ||
| Q4 25 | $1.9B | $2.8B | ||
| Q3 25 | $332.7M | $2.8B | ||
| Q2 25 | $1.6B | $2.8B | ||
| Q1 25 | $973.1M | $2.7B | ||
| Q4 24 | $1.0B | $2.6B | ||
| Q3 24 | $2.6B | $2.5B | ||
| Q2 24 | $1.1B | $2.4B |
| Q1 26 | — | $281.0M | ||
| Q4 25 | $358.1M | $245.0M | ||
| Q3 25 | $900.0K | $245.0M | ||
| Q2 25 | $319.7M | $282.0M | ||
| Q1 25 | $130.0M | $220.0M | ||
| Q4 24 | $210.9M | $222.0M | ||
| Q3 24 | $595.7M | $226.0M | ||
| Q2 24 | $148.2M | $229.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | 32.4% | ||
| Q3 25 | — | 33.7% | ||
| Q2 25 | — | 34.2% | ||
| Q1 25 | — | 32.5% | ||
| Q4 24 | — | 32.7% | ||
| Q3 24 | — | 32.6% | ||
| Q2 24 | — | 33.5% |
| Q1 26 | — | 15.4% | ||
| Q4 25 | 24.3% | 13.8% | ||
| Q3 25 | 25.8% | 13.7% | ||
| Q2 25 | 28.0% | 15.9% | ||
| Q1 25 | 17.6% | 13.0% | ||
| Q4 24 | 25.7% | 13.8% | ||
| Q3 24 | 29.9% | 13.3% | ||
| Q2 24 | 20.5% | 14.8% |
| Q1 26 | — | 9.7% | ||
| Q4 25 | 18.8% | 8.7% | ||
| Q3 25 | 0.3% | 8.7% | ||
| Q2 25 | 20.3% | 10.2% | ||
| Q1 25 | 13.4% | 8.3% | ||
| Q4 24 | 20.4% | 8.5% | ||
| Q3 24 | 22.6% | 9.1% | ||
| Q2 24 | 13.9% | 9.6% |
| Q1 26 | — | $2.24 | ||
| Q4 25 | $0.96 | $2.18 | ||
| Q3 25 | $0.00 | $2.16 | ||
| Q2 25 | $0.87 | $2.47 | ||
| Q1 25 | $0.35 | $1.94 | ||
| Q4 24 | $0.56 | $1.95 | ||
| Q3 24 | $1.63 | $1.99 | ||
| Q2 24 | $0.40 | $2.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $2.0B | $393.0M |
| Total DebtLower is stronger | — | $5.7B |
| Stockholders' EquityBook value | $7.1B | $7.7B |
| Total Assets | $29.1B | $16.7B |
| Debt / EquityLower = less leverage | — | 0.74× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $393.0M | ||
| Q4 25 | $2.0B | $420.0M | ||
| Q3 25 | $2.2B | $432.0M | ||
| Q2 25 | $1.3B | $319.0M | ||
| Q1 25 | $1.2B | $188.0M | ||
| Q4 24 | $1.3B | $549.0M | ||
| Q3 24 | $1.4B | $764.0M | ||
| Q2 24 | $914.8M | $271.0M |
| Q1 26 | — | $5.7B | ||
| Q4 25 | — | $5.2B | ||
| Q3 25 | — | $5.2B | ||
| Q2 25 | — | $5.2B | ||
| Q1 25 | — | $5.9B | ||
| Q4 24 | — | $5.6B | ||
| Q3 24 | — | $5.6B | ||
| Q2 24 | — | $3.8B |
| Q1 26 | — | $7.7B | ||
| Q4 25 | $7.1B | $7.2B | ||
| Q3 25 | $6.8B | $7.3B | ||
| Q2 25 | $6.7B | $7.2B | ||
| Q1 25 | $6.4B | $6.9B | ||
| Q4 24 | $6.3B | $6.8B | ||
| Q3 24 | $6.3B | $6.8B | ||
| Q2 24 | $5.7B | $6.6B |
| Q1 26 | — | $16.7B | ||
| Q4 25 | $29.1B | $16.2B | ||
| Q3 25 | $27.1B | $16.2B | ||
| Q2 25 | $25.1B | $16.0B | ||
| Q1 25 | $24.1B | $15.8B | ||
| Q4 24 | $23.1B | $16.2B | ||
| Q3 24 | $22.7B | $16.1B | ||
| Q2 24 | $22.3B | $13.9B |
| Q1 26 | — | 0.74× | ||
| Q4 25 | — | 0.72× | ||
| Q3 25 | — | 0.71× | ||
| Q2 25 | — | 0.72× | ||
| Q1 25 | — | 0.85× | ||
| Q4 24 | — | 0.83× | ||
| Q3 24 | — | 0.83× | ||
| Q2 24 | — | 0.58× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.2B | $278.0M |
| Free Cash FlowOCF − Capex | $-1.2B | — |
| FCF MarginFCF / Revenue | -65.1% | — |
| Capex IntensityCapex / Revenue | 2.2% | 3.9% |
| Cash ConversionOCF / Net Profit | -3.34× | 0.99× |
| TTM Free Cash FlowTrailing 4 quarters | $-3.4B | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $278.0M | ||
| Q4 25 | $-1.2B | $465.0M | ||
| Q3 25 | $-1.6B | $563.0M | ||
| Q2 25 | $-168.8M | $544.0M | ||
| Q1 25 | $-352.1M | $314.0M | ||
| Q4 24 | $-352.8M | $464.0M | ||
| Q3 24 | $791.9M | $356.0M | ||
| Q2 24 | $-1.3B | $360.0M |
| Q1 26 | — | — | ||
| Q4 25 | $-1.2B | $307.0M | ||
| Q3 25 | $-1.6B | $419.0M | ||
| Q2 25 | $-186.3M | $436.0M | ||
| Q1 25 | $-368.8M | $197.0M | ||
| Q4 24 | $-379.5M | $341.0M | ||
| Q3 24 | $772.8M | $250.0M | ||
| Q2 24 | $-1.3B | $268.0M |
| Q1 26 | — | — | ||
| Q4 25 | -65.1% | 10.9% | ||
| Q3 25 | -475.7% | 14.9% | ||
| Q2 25 | -11.8% | 15.8% | ||
| Q1 25 | -37.9% | 7.4% | ||
| Q4 24 | -36.8% | 13.0% | ||
| Q3 24 | 29.3% | 10.0% | ||
| Q2 24 | -120.4% | 11.2% |
| Q1 26 | — | 3.9% | ||
| Q4 25 | 2.2% | 5.6% | ||
| Q3 25 | 7.0% | 5.1% | ||
| Q2 25 | 1.1% | 3.9% | ||
| Q1 25 | 1.7% | 4.4% | ||
| Q4 24 | 2.6% | 4.7% | ||
| Q3 24 | 0.7% | 4.3% | ||
| Q2 24 | 1.7% | 3.8% |
| Q1 26 | — | 0.99× | ||
| Q4 25 | -3.34× | 1.90× | ||
| Q3 25 | -1732.78× | 2.30× | ||
| Q2 25 | -0.53× | 1.93× | ||
| Q1 25 | -2.71× | 1.43× | ||
| Q4 24 | -1.67× | 2.09× | ||
| Q3 24 | 1.33× | 1.58× | ||
| Q2 24 | -8.57× | 1.57× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CG
| Fund Management Fee | $606.8M | 32% |
| Other | $528.7M | 28% |
| Global Private Equity Segment | $307.3M | 16% |
| Global Credit Segment | $238.0M | 13% |
| Carlyle Alp Invest Segment | $124.6M | 7% |
| Incentive Fee | $55.4M | 3% |
| Fee Related Performance Revenues | $29.2M | 2% |
| Investment Advice | $11.1M | 1% |
DGX
Segment breakdown not available.
